ERBB2 and colorectal carcinoma: To further elucidate the association between HER2 status and sensitivity to commonly used chemotherapeutic agents in CRC, we conducted an exploratory analysis using PDTOs, a model system whose biological characteristics are considered intermediate between in vivo patient tumors and conventional in vitro cell lines.